Ph3 study to compare the combo in Golca+R with follicular lymphoma (GOLSEEK-4)
Phase III Clinical Trial
A Phase 3 Multicenter Randomized Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator�s Choice in Participants with Relapsed/Refractory Follicular Lymphoma who have Received at least 1 Prior Line of Systemic Therapy
Participating Locations